Dexcom vs Libre for Pregnancy: CGM Comparison 2026

If you've been advised to use a continuous glucose monitor (CGM) for gestational diabetes, you'll quickly discover that the two main options—Dexcom G7 and Abbott FreeStyle Libre 3—each have passionate advocates. Both are excellent devices and both are FDA-approved for use in pregnancy. But they have meaningful differences that matter for pregnant women specifically. Here's the complete 2026 comparison.

Why CGMs Are Increasingly Recommended for GD in 2026

Before comparing devices, it's worth noting that the evidence base for CGMs in gestational diabetes has significantly strengthened. A 2025 AJOG meta-analysis confirmed:

• CGM reduced large-for-gestational-age births (53% vs. 69%)
• Neonatal hypoglycemia was lower with CGM (15% vs. 28%)
• NICU admissions decreased (27% vs. 43%)
• The 2026 ADA Standards now include updated CGM guidance specific to GD

Head-to-Head Comparison: Dexcom G7 vs. FreeStyle Libre 3

Accuracy

Verdict: Libre 3 has a slight edge in general accuracy; for pregnancy-specific use, results are more variable and healthcare providers often recommend occasional fingerstick verification regardless of which CGM you use.

Sensor Wear Time and Practicality

Verdict: FreeStyle Libre 3 wins on fewer sensor changes (less expense, fewer application moments). Dexcom G7 wins on faster warmup. Both are easy to apply and comfortable to wear.

Alerts and Notifications

Verdict: Dexcom G7 wins clearly on alerts. The 20-minute predictive low alert is a significant advantage, particularly for pregnant women on insulin who face greater hypoglycemia risk. Being warned before your glucose drops below target allows you to act before symptoms occur.

Data Update Frequency

Verdict: FreeStyle Libre 3's once-per-minute readings provide more granular data. For most gestational diabetes use, 5-minute intervals are more than sufficient. The ability to use a standalone receiver (not requiring a smartphone) gives Dexcom an edge for some users.

Insulin Pump Integration

Dexcom G7: Integrates with several major insulin pump platforms for automated insulin delivery (closed-loop systems). This is a significant advantage for women with type 1 diabetes who are pregnant and using insulin pump therapy.

FreeStyle Libre 3: Limited insulin pump integration compared to Dexcom. Less suitable for women needing pump-CGM integration.

Verdict: Dexcom G7 wins for insulin pump users.

Cost and Insurance

Verdict: FreeStyle Libre 3 wins on cost when paying out-of-pocket—approximately half the monthly cost of Dexcom G7. For insured users, the difference depends on formulary placement.

Which Should You Choose?

Choose Dexcom G7 If:

• You're using insulin and want predictive hypoglycemia alerts
• You're using an insulin pump and need CGM-pump integration
• Your insurer covers Dexcom at lower cost-sharing than Libre
• You want the option of a standalone receiver (no smartphone needed)
• You have type 1 diabetes complicating your pregnancy

Choose FreeStyle Libre 3 If:

• You're managing GD with diet alone or with metformin (lower hypoglycemia risk)
• Cost is a significant factor (lower out-of-pocket cost)
• Your insurer covers Libre at lower cost-sharing
• You prefer fewer sensor changes (14-day vs. 10-day)
• You prefer the smaller sensor form factor

2026 CGM Glucose Targets for Pregnancy

Regardless of which CGM you use, the updated 2026 CGM targets for gestational diabetes are:

• Time-in-range (63-140 mg/dL): ≥70% of readings
• Time below range (<63 mg/dL): <4%
• Time above range (>140 mg/dL): <25%
• Mean glucose: <120-130 mg/dL

For insurance coverage guidance, see CGM insurance coverage for pregnancy 2026. For a broader glucose monitor review including traditional meters, see our top 7 glucose monitors for pregnancy 2026.

This content is for informational purposes only and is not medical advice. Always consult your healthcare provider or registered dietitian for personalized guidance.